Investigators' Corner| Volume 51, ISSUE 6, P825-826, November 2012

Download started.


Last Man Standing—Survival Analysis

  • Daniel C. Jupiter
    Address correspondence to: Daniel C. Jupiter, PhD, 2401 South 31st Street, Temple, TX 76508.
    Assistant Professor of Surgery, Department of Surgery, Texas A&M Health Science Center, College of Medicine; Research Scientist I, Scott and White Memorial Clinic and Hospital; and Research Assistant, Central Texas VA Health Care System, Temple, TX
    Search for articles by this author
Published:August 31, 2012DOI:


      Most studies that involve following patient outcomes for long periods of time are subject to loss of patients to follow-up. To account for such loss while gleaning the maximal amount of information from the data available requires special techniques.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The Journal of Foot and Ankle Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Shibuya N.
        • Jupiter D.C.
        • Clawson L.D.
        • La Fontaine J.
        Incorporation of bovine-based structural bone grafts used in reconstructive foot surgery.
        J Foot Ankle Surg. 2012; 51: 30-33
        • Kowalski T.J.
        • Matsuda M.
        • Sorenson M.D.
        • Gundrum J.D.
        • Agger W.A.
        The effect of residual osteomyelitis at the resection margin in patients with surgically treated diabetic foot infection.
        J Foot Ankle Surg. 2011; 50: 171-175
        • Spruance S.L.
        • Reid J.E.
        • Grace M.
        • Samore M.
        Hazard ratio in clinical trials.
        Antimicrob Agents Chemother. 2004; 48: 2787-2792